Suppr超能文献

由于局部 DNA 低甲基化导致亚基因尺度上的突变率异质性。

Mutation rate heterogeneity at the sub-gene scale due to local DNA hypomethylation.

机构信息

Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), 08028 Barcelona, Spain.

Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

出版信息

Nucleic Acids Res. 2024 May 8;52(8):4393-4408. doi: 10.1093/nar/gkae252.

Abstract

Local mutation rates in human are highly heterogeneous, with known variability at the scale of megabase-sized chromosomal domains, and, on the other extreme, at the scale of oligonucleotides. The intermediate, kilobase-scale heterogeneity in mutation risk is less well characterized. Here, by analyzing thousands of somatic genomes, we studied mutation risk gradients along gene bodies, representing a genomic scale spanning roughly 1-10 kb, hypothesizing that different mutational mechanisms are differently distributed across gene segments. The main heterogeneity concerns several kilobases at the transcription start site and further downstream into 5' ends of gene bodies; these are commonly hypomutated with several mutational signatures, most prominently the ubiquitous C > T changes at CpG dinucleotides. The width and shape of this mutational coldspot at 5' gene ends is variable across genes, and corresponds to variable interval of lowered DNA methylation depending on gene activity level and regulation. Such hypomutated loci, at 5' gene ends or elsewhere, correspond to DNA hypomethylation that can associate with various landmarks, including intragenic enhancers, Polycomb-marked regions, or chromatin loop anchor points. Tissue-specific DNA hypomethylation begets tissue-specific local hypomutation. Of note, direction of mutation risk is inverted for AID/APOBEC3 cytosine deaminase activity, whose signatures are enriched in hypomethylated regions.

摘要

人类的局部突变率高度不均一,在兆碱基大小的染色体域范围内存在已知的可变性,而在另一方面,在寡核苷酸范围内也存在可变性。在中间的千碱基尺度上,突变风险的异质性则不太为人所知。在这里,通过分析数千个人体细胞基因组,我们研究了基因体中突变风险的梯度,代表了跨越大约 1-10 kb 的基因组尺度,假设不同的突变机制在基因片段中分布不同。主要的异质性涉及转录起始位点附近的几个千碱基以及基因体的 5' 末端进一步下游的区域;这些区域通常由于几种突变特征而出现低突变,其中最突出的是 CpG 二核苷酸处普遍存在的 C>T 变化。这种 5' 基因末端突变冷点的宽度和形状在基因之间是可变的,并且与可变的 DNA 甲基化间隔相对应,具体取决于基因活性水平和调节。这种在 5' 基因末端或其他位置的低突变区域对应于 DNA 低甲基化,它可以与各种标记相关联,包括基因内增强子、多梳标记区域或染色质环锚点。组织特异性的 DNA 低甲基化导致组织特异性的局部低突变。值得注意的是,AID/APOBEC3 胞嘧啶脱氨酶活性的突变风险方向相反,其特征在低甲基化区域中富集。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9cc/11077091/e447066759d8/gkae252figgra1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验